AccuVein is a global leader in medical imaging solutions, specifically focusing on vein visualization.
The company’s AV500 device allows health care professionals to see a map of peripheral veins on the skin's surface. This helps them access veins during IV starts, blood draws, and sclerotherapy, and avoid veins during surgical and cosmetic procedures. Vein visualization has been shown to increase the success of venipuncture procedures as well as reduce pain, costs, and the rate of escalation calls due to an inability to cannulate.
The AV500 is built on AccuVein's proprietary technology, which encompasses more than 40 patents covering a broad range of imaging and medical diagnostic technologies. AccuVein is in use at more than 3,000 hospitals and available for sale in 125 countries worldwide.
AccuVein is based in Cold Spring Harbor, NY. Hugo Harrod and Akhilesh Pathipati represent MVM’s investment in the company and Hugo has joined the Board of Directors.